Sotalol is a non-selective beta-adrenergic blocker with class III antiarrhythmic properties, primarily indicated for the treatment of life-threatening ventricular arrhythmias and atrial fibrillation. Because… Read more






![Chemical structure of N-[2-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-6-methylphenyl]methanesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F480444-15-3-N-2-4S-45-Dihydro-4-1-methylethyl-2-oxazolyl-6-methylphenylmethanesulfonamide.png&w=3840&q=75)











Sotalol is a non-selective beta-adrenergic blocker with class III antiarrhythmic properties, primarily indicated for the treatment of life-threatening ventricular arrhythmias and atrial fibrillation. Because accurate pharmaceutical analysis is essential for drug safety, this category provides a comprehensive range of Sotalol reference standards. Laboratories utilize these high-quality compounds, including pharmacopeial and non-pharmacopeial impurities such as deoxysotalol and various N-nitroso derivatives, to facilitate rigorous impurity profiling. To ensure precision in analytical method validation, particularly for high-performance liquid chromatography and mass spectrometry, stable isotope labelled Sotalol variants are available to serve as internal standards. These materials support the pharmaceutical industry in monitoring potential degradation products and ensuring strict compliance with regulatory quality control requirements throughout the drug development and manufacturing lifecycle.